Asunto(s)
Peces/inmunología , Hipersensibilidad a los Alimentos/inmunología , Animales , Preescolar , Humanos , MasculinoRESUMEN
SUMMARY: We report the case of a 36-year-old male pharmaceutical laboratory worker. On handling Spagulax® sachets whose content is a laxative called Plantago ovata, he immediately presented rhinoconjunctivitis. Methods. Specific allergy study included SDS-PAGE with Western Blot and specific nasal challenge to Plantago ovata extract. Results. Prick by prick for Spagulax® was negative. Total IgE: 126.5 U/mL. Western Blot recognized two proteins of 15 and 20 kDa in the extract of Plantago ovata and three proteins of 15, 18 and 50 kDa in the extract of Plantago lanceolata. Conclusions. We present a case of occupational allergy due to inhalation of and/or contact with Plantago ovata seeds.
Asunto(s)
Conjuntivitis Alérgica/inducido químicamente , Hipersensibilidad a las Drogas/inmunología , Laxativos/efectos adversos , Enfermedades Profesionales/inmunología , Exposición Profesional/efectos adversos , Preparaciones de Plantas/efectos adversos , Plantago/efectos adversos , Rinitis Alérgica/inducido químicamente , Adulto , Western Blotting , Conjuntivitis Alérgica/diagnóstico , Conjuntivitis Alérgica/inmunología , Hipersensibilidad a las Drogas/diagnóstico , Industria Farmacéutica , Humanos , Inmunoglobulina E/inmunología , Pruebas Intradérmicas , Personal de Laboratorio , Masculino , Enfermedades Profesionales/diagnóstico , Preparaciones de Plantas/inmunología , Plantago/inmunología , Rinitis Alérgica/diagnóstico , Rinitis Alérgica/inmunologíaRESUMEN
BACKGROUND AND OBJECTIVES: The homologous group of sweet grasses belongs to the Pooideae subfamily, but grass pollen species from other subfamilies can also cause allergy, such as Cynodon dactylon (Chloridoideae) and Phragmites communis (Arundinoideae). C dactylon and P communis have not been included in the sweet grasses homologous group because of their low cross-reactivity with other grasses. The aims of this study were to investigate the profile of sensitization to C dactylon and P communis in patients sensitized to grasses and to analyze cross-reactivity between these 2 species and temperate grasses. METHODS: Patients were skin prick tested with a grass mixture (GM). Specific IgE to GM, C dactylon, P communis, Cyn d 1, and Phl p 1 was measured by ImmunoCAP. A pool of sera was used for the immunoblot assays. Cross-reactivity was studied by ELISA and immunoblot inhibition. RESULTS: Thirty patients had sIgE to GM. Twenty-four (80%) had positive results for C dactylon, 27 (90%) for P communis, 22 (73.3%) for nCyn d 1, and 92.9% for rPhl p 1. Bands were detected in the 3 extracts by immunoblot. Inhibition of GM was not observed with C dactylon or P communis by immunoblot or ELISA inhibition. When C dactylon or P communis were used in the solid phase, GM produced almost complete inhibition. CONCLUSIONS: Eighty percent of patients sensitized to grasses were also sensitized to C dactylon and 90% were sensitized to P communis. Sensitization to these species seems to be induced by allergens different to those in sweet grasses.
Asunto(s)
Alérgenos/inmunología , Antígenos de Plantas/inmunología , Reacciones Cruzadas/inmunología , Cynodon/inmunología , Poaceae/inmunología , Adulto , Femenino , Humanos , Hipersensibilidad/inmunología , Inmunoglobulina E/inmunología , Masculino , Persona de Mediana Edad , Proteínas de Plantas/inmunología , Polen/inmunología , Adulto JovenRESUMEN
Topical application of antihistamines commonly leads to sensitization for patients, but systemic administration of antihistamines rarely induces allergic hypersensitivity, which is mainly linked to phenothiazine-derived and piperazine-derived compounds. We report a 70-year-old woman whose medical history included lichen planus, and who was referred by the dermatology department of our hospital for suspected allergy to corticosteroids. The reason for referral was that on the fourth day of treatment with prednisone and hydroxyzine, the patient presented a bilateral highly pruritic palmar erythema that evolved to a generalized morbilliform rash with subsequent complete desquamation. At a later time, she took cetirizine for a cold, and developed palmar erythema and desquamation. Skin tests (prick and intradermal tests) were performed with steroids, and patch tests (read after 48 and 96 h) with corticosteroids and antihistamines. Controlled oral challenge tests were performed with prednisone and with an alternative antihistamine. Skin tests were negative for all corticosteroids. Patch tests were negative for all corticosteroids, but the antihistamine test was positive for hydroxyzine. Oral challenge with prednisone and dexchlorpheniramine was negative. The patient was diagnosed with cutaneous drug eruption from hydroxyzine and cetirizine. We consider it is important to assess every patient whose skin condition worsens after treatment with antihistamines, especially hydroxyzine, because it is known that antihistamines are often not recognised as the culprit in cases of cutaneous eruption.
Asunto(s)
Erupciones por Medicamentos/etiología , Dermatosis de la Mano/inducido químicamente , Antagonistas de los Receptores Histamínicos H1/efectos adversos , Hidroxizina/efectos adversos , Anciano , Eritema/inducido químicamente , Femenino , Humanos , Prurito/etiologíaRESUMEN
OBJECTIVE: We present two adult and three paediatric patients who had allergic reactions after cheese ingestion and subsequently tolerated cow's milk derivatives. The objective of this study was to determine possible cross-reactivity between different types of cheese. METHODS: Skin tests were performed to cow's milk fractions, and prick-prick tests for goat, sheep and cow cheese. Specific IgE to the fractions of cow's milk and cow, sheep and goat cheese was analysed. The protein profile of cow, sheep and goat cheese extracts was determined by SDS-PAGE and the allergenic profile by immunoblot. Cross-reactivity was investigated by immunoblot inhibition. RESULTS: Skin tests were positive for casein in the patients. The prick-prick tests were positive for the three cheeses in patients 1 and 4, for goat and sheep cheese in patients 2 and 3, and for sheep cheese in patient 5. The specific IgE test was positive in patients 1, 3 and 4 for goat and sheep cheese, and negative in patients 2 and 5. Serum 3 and 4 clearly recognised goat and sheep cheese extracts. Goat casein was almost completely inhibited with sheep casein and partially inhibited with goat and sheep serum proteins, while there was no inhibition with cow cheese. Sheep casein was totally inhibited with sheep serum proteins. Sheep casein was inhibited with goat and cow caseins, suggesting cross-reactivity among the three types of cheese. CONCLUSIONS: We showed sensitisation to goat and sheep cheese in two patients, and only to sheep cheese in another two of the studied patients.
Asunto(s)
Anafilaxia/inmunología , Queso/efectos adversos , Reacciones Cruzadas/inmunología , Hipersensibilidad a la Leche/inmunología , Leche/inmunología , Alérgenos/inmunología , Animales , Caseínas/inmunología , Bovinos , Niño , Femenino , Cabras , Humanos , Tolerancia Inmunológica , Inmunoglobulina E/sangre , Masculino , Persona de Mediana Edad , Ovinos , Pruebas CutáneasRESUMEN
BACKGROUND: Good control of allergic rhinitis (AR) in children is desirable because it is associated with diseases such as asthma. The aim of this analysis of the PETRA study was to characterise its diagnosis and treatment in Spanish children. METHODS: Data were analysed for paediatric patients (age 5-17 years, inclusive) included in the PETRA study, which included consecutive patients with allergic rhinitis attending respiratory specialists throughout Spain. Demographic information, disease characteristics (duration, severity according to the Allergic Rhinitis and its Impact on Asthma [ARIA] classification), diagnostic procedures, treatments and physicians' attitudes to treatment were recorded. RESULTS: Of the original sample of 1043 patients, 260 children were included (mean age, 11.7 years; 56.2% boys; 61.9% allergic to house dust mites (HDM) and 38.1% allergic to grass pollen). By ARIA classification, 180/260 (69.4%) had persistent AR and 176/280 (63%) had moderate disease. Asthma was reported in 89/161 (55%) with HDM allergy and 44/99 (45%) with grass pollen allergy. Symptomatic treatment was prescribed in 98.5%, although disease control had been no better than poor in 57.3%. Allergen specific immunotherapy was administered to 56.9%, and was used more often for HDM AR. When asked why specific immunotherapy was not prescribed, two-thirds of the investigators preferred a wait-and-see approach, prescribing immunotherapy if symptoms worsened or asthma developed. CONCLUSIONS: Paediatric patients treated by specialists for allergic rhinitis have moderate or severe disease. Symptomatic treatment was extensively prescribed but often did not achieve good disease control. Many specialists preferred a wait-and-see approach before prescribing immunotherapy.
Asunto(s)
Desensibilización Inmunológica/estadística & datos numéricos , Hipersensibilidad/diagnóstico , Hipersensibilidad/terapia , Rinitis/diagnóstico , Rinitis/terapia , Niño , Preescolar , Femenino , Humanos , Masculino , Pautas de la Práctica en Medicina , EspañaRESUMEN
BACKGROUND: Different opinion documents point to a patient age of under five years as a relative contraindication to specific immunotherapy, arguing that this age group has a greater risk of developing anaphylaxis, and that specially trained personnel are needed to deal with the problem if it occurs. However, insufficient evidence exists to support such an affirmation. PATIENTS AND METHODS: A retrospective follow-up observational study was made of patients aged 60 months or younger who had been subjected to specific immunotherapy. We included 77 children with a diagnosis of extrinsic bronchial asthma (n=68), extrinsic spasmodic cough (n=5) and allergic rhinitis (n=4) confirmed by clinical criteria and prick-test, with specific IgE positivity to Dermatophagoides pteronyssinus. All patients received specific immunotherapy with an extract of depigmented D. pteronyssinus polymerised with glutaraldehyde, involving an initial cluster protocol of two weeks and monthly maintenance doses. All observed adverse reactions were recorded, and classified according to European Academy of Allergy and Clinical Immunology (EAACI) criteria. RESULTS: A total of 1837 doses were administered to the 77 patients, with four adverse reactions being observed in three patients. Three reactions (0.16% of the administered doses) were local and immediate, while one was systemic and of grade 2 (0.05% of the administered doses) - consisting of an episode of nocturnal wheezing. CONCLUSIONS: Specific immunotherapy in children under five years of age with the extract used is safe. We consider that further studies are needed, involving other types of extracts, to allow reconsideration of the relative contraindication of patient age for the administration of immunotherapy.
Asunto(s)
Antígenos Dermatofagoides/administración & dosificación , Asma/inmunología , Mezclas Complejas/administración & dosificación , Desensibilización Inmunológica , Rinitis Alérgica Perenne/inmunología , Animales , Antígenos Dermatofagoides/efectos adversos , Antígenos Dermatofagoides/química , Asma/complicaciones , Asma/tratamiento farmacológico , Asma/fisiopatología , Preescolar , Mezclas Complejas/efectos adversos , Mezclas Complejas/química , Dermatophagoides pteronyssinus , Femenino , Estudios de Seguimiento , Glutaral/química , Humanos , Inmunoglobulina E/inmunología , Lactante , Masculino , Pigmentos Biológicos/química , Pigmentos Biológicos/metabolismo , Polimerizacion , Estudios Retrospectivos , Rinitis Alérgica Perenne/complicaciones , Rinitis Alérgica Perenne/tratamiento farmacológico , Rinitis Alérgica Perenne/fisiopatologíaRESUMEN
OBJECTIVE: To assess the allergenic capacity of a new extensively hydrolysed casein formula (Damira 2000) in vivo in children with allergy to cow's milk, and to conduct an immunochemical evaluation of the product. PATIENTS AND METHODS: The study comprised 67 children (1 month-7 years) with allergy to cow's milk proteins (ACMP). Skin testing was made with whole milk, milk formula for infants, the study hydrolysate and the milk fractions (alpha-lactoalbumin, beta-lactoglobulin and casein). Specific IgE against these allergens, and oral provocation test were also performed. Immunochemical evaluation of the product was carried out with gel filtration chromatography, 4-15% acrylamide gradient gel electrophoresis, specific IgE quantification versus the casein hydrolysate and a study of its allergenic potency. RESULTS: The hydrolysate was tolerated by 66 of the 67 patients (98.5%) with ACMP. Biochemical analysis of the product confirmed the absence of traces of whole milk proteins. Specific IgE against the hydrolysate proved negative in all cases, and it was unable to inhibit FEIA even at concentrations 10 times greater than those used in the whole milk inhibition control. Likewise, no immunoblotting inhibition was recorded. CONCLUSIONS: The new extensively hydrolysed casein product is safe and well tolerated by most children with ACMP. However, as with other extensive hydrolysates, some highly sensitised patients may present clinical manifestations. Controlled tolerance testing is therefore advised, under specialised medical supervision.
Asunto(s)
Inmunoglobulina E/inmunología , Fórmulas Infantiles/administración & dosificación , Hipersensibilidad a la Leche/inmunología , Proteínas de la Leche/efectos adversos , Caseínas/administración & dosificación , Caseínas/efectos adversos , Niño , Preescolar , Femenino , Humanos , Inmunoglobulina E/sangre , Lactante , Masculino , Proteínas de la Leche/administración & dosificación , Estudios Prospectivos , EspañaRESUMEN
OBJECTIVE: To develop and validate a questionnaire to assess asthma control in children (CAN). DESIGN: Two versions of the CAN (for carers and children) were developed. Both versions were validated in an observational, prospective, multicenter study performed in 38 hospital outpatient clinics throughout Spain. Four hundred fifteen patients and their carers agreed to participate. Of these, 414 patients under 14 years old with frequent episodic or persistent (moderate to severe) asthma completed the questionnaire on 3 occasions (baseline, week 2, and week 12). For patients aged 2-8 the questionnaire was only completed by the carers, but for patients aged 9-14 the questionnaire was completed by the carers and the children. Clinician ratings of asthma control were used as a gold standard to assess the sensitivity, specificity, PPV and NPV of the new measure. RESULTS: Evaluable responses were obtained from 215 carers for children aged 2-8 years and 199 children aged 9-14 years, and their parents. Using a questionnaire total score cut-off of 8 the patient version had a sensitivity of 76.3% and a specificity of 62.9%. For carer version these values were 73% and 69.7%, respectively. A cut point of 8 was selected to maximize the screening accuracy of the CAN questionnaire. Effect sizes in patients with clinician-rated improvements in asthma control were 0.33 and 0.57 for the carer and child versions, respectively. CONCLUSIONS: The screening accuracy and validity of the CAN questionnaire make it suitable for use in research and clinical practice. The sensitivity and specificity were close to 70%, which is acceptable for the study objective: obtain a tool to measure the level of asthma control.
Asunto(s)
Asma/diagnóstico , Encuestas y Cuestionarios , Adolescente , Niño , Preescolar , Femenino , Humanos , Masculino , Tamizaje Masivo , Reproducibilidad de los Resultados , Sensibilidad y EspecificidadRESUMEN
Patients who are allergic to latex (Hevea brasiliensis) may exhibit cross-hypersensitivity with foods. We present a case of anaphylaxis due to cassava in a patient suffering from pollinosis, latex allergy, and latex-fruit syndrome. We performed sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting with cassava, avocado, chestnut, banana, kiwi, and latex extracts in order to analyze the protein bands and their molecular weights, and identify immunoglobulin (Ig) E-binding bands. Immunoblot inhibition and enzyme-linked immunosorbent assay (ELISA) inhibition were performed with latex in order to assess cross-reactivity. Cassava exhibited numerous protein bands, 5 of which were IgE-binding (89.75, 46.28, 26.68, 21.38, and 19.49 kd). These cassava IgE-binding bands were 100% inhibited by preincubation of the patient's serum with latex extract. The ELISA inhibition between latex and cassava was 23%. Our results confirm cassava as another food with clinical cross-reactivity in patients suffering from latex allergy.
Asunto(s)
Hipersensibilidad a los Alimentos/inmunología , Látex/inmunología , Manihot/inmunología , Adulto , Reacciones Cruzadas , Femenino , Hipersensibilidad a los Alimentos/etiología , Humanos , Hipersensibilidad al Látex/inmunologíaRESUMEN
BACKGROUND: The clinical efficacy of allergen immunotherapy using therapeutic vaccines containing modified allergen extracts has been previously shown. OBJECTIVE: To evaluate the clinical efficacy of a vaccine containing depigmented, polymerized extract of Dermatophagoides pteronyssinus in asthmatic children, monosensitized to mites, after 4 months of treatment. MATERIAL AND METHODS: A total of 30 mite-allergic, asthmatic children (age range, 8-16 years) were entered in the study; 15 were treated with the modified allergen extract (active group) and 15 received only pharmacologic treatment (control group). The study was open, controlled and parallel with random allocation of the patients to each of the groups. Efficacy was evaluated using allergen-specific bronchial challenge tests, dose-response skin-prick tests, and symptom and medication scores. The results of the bronchial challenges and dose-response skin-prick tests were compared at baseline and after 4 months of treatment. The build up phase consisted of 4 injections in 2 days, followed by 4 injections of the maintenance dose. RESULTS: All patients of the active group concluded the study, whereas 2 of the control group did not. In the active group, there was a significant difference in the PC20FEV1 (P <.01) after 4 months. The mean allergen quantity needed was 26 microg at baseline vs. 309 microg after 4 months (a 12.8-fold increase). There was no difference in the control group (5 tg at baseline vs 8 microg at the end). A significant reduction in the number of cases with dual bronchial response was observed in the treated group (P < .05). Two treated patients of this group experienced a negative bronchial challenge after 4 months of treatment. The group of active patients also experienced significant improvement in skin reactivity and symptom and medication scores. CONCLUSIONS: Vaccines containing depigmented polymerized extracts of D pteronyssinus are safe and effective in the treatment of mite allergic asthmatic children, and provide clinical benefit after 4 months of treatment.
Asunto(s)
Antígenos Dermatofagoides/inmunología , Asma/inmunología , Hiperreactividad Bronquial/inmunología , Dermatophagoides pteronyssinus/química , Adolescente , Animales , Antígenos Dermatofagoides/uso terapéutico , Asma/terapia , Hiperreactividad Bronquial/terapia , Pruebas de Provocación Bronquial/métodos , Niño , Desensibilización Inmunológica/métodos , Esquema de Medicación , Femenino , Humanos , Masculino , Pruebas Cutáneas , Resultado del TratamientoAsunto(s)
Angioedema/etiología , Venenos de Abeja/efectos adversos , Venenos de Abeja/inmunología , Hipersensibilidad a los Alimentos/diagnóstico , Hipersensibilidad a los Alimentos/inmunología , Miel/efectos adversos , Himenópteros/inmunología , Extractos de Tejidos/inmunología , Alérgenos/efectos adversos , Alérgenos/inmunología , Angioedema/inmunología , Animales , Especificidad de Anticuerpos/inmunología , Niño , Electroforesis en Gel de Poliacrilamida , Humanos , Immunoblotting , Inmunoglobulina E/sangre , Inmunoglobulina E/inmunología , Pruebas Cutáneas , Extractos de Tejidos/efectos adversosRESUMEN
Gastroesophageal reflux has been named as a possible etiologic factor in infant asthma. We studied 28 boys and six girls aged 19.4 +/- 4.8 months whose asthma began at the age of 7.5 months (1 to 28 months). A common protocol including allergy tests and 24-h intraesophageal pH monitoring (IEpHM) was used. Patients with pathologic 24-h IEpHM were treated with cisapride while the rest were considered the control group. Symptoms score and drug consumption were evaluated in both groups, and 24-h IEpHM was repeated at 4 months. IEPHM was pathologic in 65.6% of the infants. In the cisapride group, wheezing crisis frequency decreased from 4.9 +/- 2 to 0.75 +/- 1.2 (p < 0.0002), and only 10% of patients needed basic pharmacologic treatment. The second IEpHM was normal in eight cases, pathologic in six and was not performed in seven. In the controls, wheezing crisis frequency decreased from 4.6 +/- 2.4 to 0.75 +/- 1.8 (p < 0.01), but 44% needed basic pharmacologic treatment (p < 0.05). In conclusion, gastroesophageal reflux is a frequent but not universal finding in infants with asthma; and cisapride treatment spectacularly reduces wheezing crisis frequency and antiasthmatic drug consumption in these patients.
Asunto(s)
Asma/prevención & control , Reflujo Gastroesofágico/complicaciones , Reflujo Gastroesofágico/tratamiento farmacológico , Piperidinas/uso terapéutico , Simpatomiméticos/uso terapéutico , Asma/etiología , Niño , Preescolar , Cisaprida , Femenino , Reflujo Gastroesofágico/epidemiología , Humanos , Concentración de Iones de Hidrógeno , Lactante , Masculino , Monitoreo Fisiológico , PrevalenciaRESUMEN
Veno-venous haemodialysis is an extra-renal depuration method of recent application in our Unit which adds the advantage of blood impulsion by bomb, which provides a higher control over the volume of ultrafilterring and decreases the possible haemodynamic alterations. In this work we show our experience about the incorporation of this new process, the important role that the nursing staff acquire in the circuit handling as well as in patients care. To do so, between March and October 1993 we performed a follow-up of this technique in 11 cases collecting data about complications with the circuit and patient improvement, circuit maintainance, reasons for change, volumes and balances obtained.
Asunto(s)
Hemodiafiltración/enfermería , Estudios de Seguimiento , Hemodiafiltración/efectos adversos , Hemodiafiltración/métodos , Humanos , Registros de Enfermería , Resultado del TratamientoRESUMEN
Recurrent urticaria and recurrent angioedema are frequent adverse reactions in non-atopic patients who do not tolerate aspirin. Of 1,632 infants and children who visited our allergy department for the first time, nine children (0.55%), five males and four females, presented recurrent urticaria or recurrent angioedema after taking aspirin. No evidence of atopy was disclosed either by clinical history (personal and family), skin testing, eosinophil levels or total IgE. Aspirin intolerance was established by oral challenge. Only three of the nine patients reported aspirin intolerance in their histories.
Asunto(s)
Angioedema/inducido químicamente , Aspirina/efectos adversos , Hipersensibilidad Inmediata/inmunología , Urticaria/inducido químicamente , Antibacterianos/administración & dosificación , Antibacterianos/inmunología , Niño , Preescolar , Femenino , Hipersensibilidad a los Alimentos/inmunología , Conservantes de Alimentos/administración & dosificación , Humanos , Masculino , Pruebas CutáneasRESUMEN
In 1981 a double blind study was conducted at random with Ketotifen. Fifty children were chosen at random (40 males and 10 females) who had been diagnosed as suffering from extrinsic bronchial asthma and had not undergone any previous treatment either with sodium cromoglycate or with immunotherapy. In all cases the treatment lasted 12 weeks, with monthly controls, in some cases on a weekly basis, which measured the following parameters: Daily written control by the parents of the clinical evolution. Monthly clinical examination with cardiovascular control (Cardiac frequency, T A , etc.) respiratory examination with lung function study, auxomatric control (height, weight), etc. Monthly control of the additional medication received, specifying type of medication, dosage and length of time administered (bronchodilators, antihistamines, antibiotics, etc.). Monthly control of possible collateral and side effects: subjective symptoms: neurologic, digestive, dermatologic, psychic, neuro-vegetative, genito-urinary, cardiorespiratory, etc. Analytical control at the commencement and termination of treatment which consists of: a) complete blood cell count, b) platelets and c) hepatic function study (GOT, CPT and alkaline phosphatases). The results of the overall evaluation of the group of children submitted to treatment with active substances were as follows: In asthma 70.35% was VERY EFFECTIVE and EFFECTIVE and 29.61% SLIGHTLY or NOT EFFECTIVE. In dermorespiratory cases 57.13% was VERY EFFECTIVE or EFFECTIVE and 42.85% SLIGHTLY EFFECTIVE. In concomitant rhinitis 74.93% was VERY EFFECTIVE and EFFECTIVE and 25% SLIGHTLY EFFECTIVE.(ABSTRACT TRUNCATED AT 250 WORDS)
Asunto(s)
Asma/tratamiento farmacológico , Cetotifen/uso terapéutico , Niño , Preescolar , Método Doble Ciego , Evaluación de Medicamentos , Femenino , Humanos , Cetotifen/efectos adversos , MasculinoRESUMEN
We present 25 patients, aged between 18 and 153 months, with clinical symptoms suggestive of allergy to food antigens. After undergoing exhaustive studies (including case histories, cutaneous tests for reactions to food antigen, peripheral eosinophils, secretory and humoral immunity, determination of total IgE and of specific RAST, exclusion-provocation diets) and without being able to identify an offender, patients were submitted to oral provocation with different food additives (tartrazine, sunset yellow FCF, new coccine, erythrosine, sodium benzoate, 4-methyl hydroxybenzoate and acetylsalicylic acid) after 48 hours of exclusion from their diets of dyes, preservatives and salicylates. The results obtained reflect, at a global level, 57.89% of positivities for dyes, 34.21% for the benzoates and 7.81% for acetyl-salicylic acid. The low incidence of crossed intolerance phenomena should be emphasized (32% of the patients). The disparity of our results with those of other authors could be due to the age of our patients, the clinical patterns they present and the dietary habits of different countries and regions.